OCUGEN ($OCGN) is expected to release its quarterly earnings data on Friday, May 2nd before market open, per Finnhub. Analysts are expecting revenue of $0 and earnings of -$0.06 per share.
You can see Quiver Quantitative's $OCGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
OCUGEN Insider Trading Activity
OCUGEN insiders have traded $OCGN stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $OCGN stock by insiders over the last 6 months:
- KIRSTEN CASTILLO purchased 25,000 shares for an estimated $22,847
- PRABHAVATHI FERNANDES purchased 10,000 shares for an estimated $9,095
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
OCUGEN Hedge Fund Activity
We have seen 51 institutional investors add shares of OCUGEN stock to their portfolio, and 56 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STATE STREET CORP removed 9,958,409 shares (-62.9%) from their portfolio in Q4 2024, for an estimated $8,016,519
- RENAISSANCE TECHNOLOGIES LLC added 2,087,632 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,680,543
- BLACKROCK, INC. added 1,334,443 shares (+7.2%) to their portfolio in Q4 2024, for an estimated $1,074,226
- GSA CAPITAL PARTNERS LLP added 941,423 shares (+460.8%) to their portfolio in Q4 2024, for an estimated $757,845
- RAFFERTY ASSET MANAGEMENT, LLC removed 797,331 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $641,851
- BANK OF AMERICA CORP /DE/ removed 583,634 shares (-60.7%) from their portfolio in Q4 2024, for an estimated $469,825
- CETERA INVESTMENT ADVISERS removed 414,701 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $333,834
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
